| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (DGX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. DGX is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.4K | $25.71M | -10,000 | |
| VP | 83.7K | $16.24M | - | |
| VP | 38.3K | $7.44M | - | |
| VP | 34.5K | $6.69M | - | |
| CFO | 33.4K | $6.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 | Deppe Michael J | VP, Corp. Controller &CAO | Sale+OE | 15,497 | $145.00 | $2,247,065.00 | -32.6% | +0.3% | -8.5% | |
| Oct 3, 2022 | Ring Timothy M53 | Director | Sale+OE | 2,000 | $123.39 | $246,780.00 | -7.7% | +24.2% | -3.5% | |
| Sep 1, 2022 | Ring Timothy M53 | Director | Sale+OE | 2,000 | $125.02 | $250,040.00 | -7.7% | +21.0% | +4.0% | |
| Aug 1, 2022 | Ring Timothy M53 | Director | Sale+OE | 2,000 | $136.04 | $272,080.00 | -7.7% | +5.7% | -1.0% | |
| Jul 1, 2022 | Ring Timothy M53 | Director | Sale+OE | 2,000 | $133.47 | $266,940.00 | -7.7% | -8.4% | +3.9% | |
| May 25, 2022 | Rusckowski Stephen H64 | Chairman, CEO And President | Sale+OE | 24,891 | $140.89 | $3,506,933.86 | -1.2% | -7.3% | -4.9% | |
| May 24, 2022 | Rusckowski Stephen H64 | Chairman, CEO And President | Sale+OE | 359,874 | $140.13 | $50,429,541.37 | -11.8% | -5.3% | -4.8% | |
| May 17, 2022 | Prevoznik Michael E52 | SVP &General Counsel | Sale+OE | 50,604 | $139.97 | $7,082,991.28 | -56.3% | +0.9% | -5.0% | |
| Mar 8, 2022 | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sell | 7,032 | $135.21 | $950,796.72 | -9.4% | +1.6% | +3.4% | |
| Mar 8, 2022 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 6,228 | $135.21 | $842,087.88 | -13.7% | +1.6% | +3.4% |